EMG
MACK

Ellington Management Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Ellington Management Group’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-6,279
Closed -$558K – 911
2014
Q4 		$558K Buy
+6,279
New +$558K 0.19% 163
2013
Q3 		– Sell
-5,821
Closed -$309K – 1079
2013
Q2 		$309K Buy
+5,821
New +$309K 0.06% 498